Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.

The hepatitis B vaccine is one of the very first vaccines your baby will get before she leaves the hospital. This vaccine protects her from a dangerous (but preventable!) liver infection and is given ...

Hepatitis A and B are the most common vaccine-preventable diseases for travelers; nevertheless, up to 50% of confirmed cases of hepatitis A and B in Europe are still acquired during travel.

A new study that has the potential to change the landscape of hepatitis B transmission in Africa. Researchers conducted an analysis revealing key interventions that could effectively eliminate ...

Unregistered practitioners risked infecting clients when they performed skin-penetrating procedures at Ketthip Clinic.

supported by an expanding U.S. hepatitis B vaccine market and expected market share gains. The company plans to advance its Z1018 shingles vaccine program, aiming to establish proof of concept ...

University of Leeds researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine ...

The Business Research Company's Key Market Driver In Hepagam B industry 2025: Rising Hepatitis B Prevalence To Fueling Growth It will grow to $XX million in 2029 at a compound annual growth rate (CAGR ...

Worldwide, hepatitis B is thought to be the second deadliest infection; about 5% of the global population are infection and it can lead to liver cancer. | Microbiology ...

Clients of a Sydney cosmetic clinic have been urged to undergo testing after they were potentially exposed to HIV and ...

During the period, seven children were supposed to have received the hepatitis B vaccine. But the records showed two doses were unused, while two extra shots of the 15-valent pneumococcal ...